Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Net Margin (2016)

Historic Net Margin for Tenax Therapeutics (TENX) over the last 4 years, with Q2 2013 value amounting to 7081.99%.

  • Tenax Therapeutics' Net Margin fell 157659200.0% to 7081.99% in Q2 2013 from the same period last year, while for Mar 2016 it was 516137.19%, marking a year-over-year change of. This contributed to the annual value of 76534.78% for FY2024, which is 441431200.0% up from last year.
  • Latest data reveals that Tenax Therapeutics reported Net Margin of 7081.99% as of Q2 2013, which was down 157659200.0% from 1085.17% recorded in Q1 2013.
  • Tenax Therapeutics' Net Margin's 5-year high stood at 22847.91% during Q2 2012, with a 5-year trough of 250580.02% in Q3 2010.
  • Moreover, its 4-year median value for Net Margin was 693.14% (2012), whereas its average is 18191.98%.
  • Per our database at Business Quant, Tenax Therapeutics' Net Margin surged by 2000000000bps in 2011 and then tumbled by -157659200bps in 2013.
  • Tenax Therapeutics' Net Margin (Quarter) stood at 7562.32% in 2010, then tumbled by -141bps to 3074.85% in 2011, then soared by 90bps to 301.12% in 2012, then surged by 2452bps to 7081.99% in 2013.
  • Its Net Margin stands at 7081.99% for Q2 2013, versus 1085.17% for Q1 2013 and 301.12% for Q4 2012.